BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2026.
World J Transplant. Mar 18, 2026; 16(1): 113075
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.113075
Table 2 Primary outcomes, n (%)/mean ± SD

HALDN (n = 70)
RALDN (n = 70)
P value
Duration of operation in minutes247.14 ± 109.0254.57 ± 108.20.62
Warm ischaemic time in minutes2.76 ± 1.33.53 ± 1.4< 0.001
Pain score
Day 11.84 ± 0.972.04 ± 0.840.20
Day 21.63 ± 0.891.61 ± 0.840.92
Day 30.93 ± 0.790.94 ± 0.680.91
Post-operative day at which PCA was down2.39 ± 0.712.21 ± 0.760.17
Length of hospital stay 3.17 ± 1.154.21 ± 1.75< 0.001
Complication rate9 (12.9)9 (12.9)
Clavien-Dindo II7 (10)5 (7.1)
Clavien-Dindo IIIa0 (0)1 (1.4)
Clavien-Dindo IIIb2 (2.9) 3 (4.3)1
Readmissions7 (10)5 (7.1)
Clavien-Dindo II5 (7.1)3 (4.2)
Clavien-Dindo IIIb2 (2.9)2 (2.9)0.55
Reoperations2 (2.9)2 (2.9)
Intra-abdominal sepsis1 (1.4)0 (0)
Incisional hernia1 (1.4)1 (1.4)
Wound re-exploration0 (0)1 (1.4)1
Creatinine (μmol/L)
Day 30114.87 ± 26.1110.89 ± 24.90.37
Day 365111.81 ± 28.7107.45 ± 18.80.37


Write to the Help Desk